Regions

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.

Penn Medicine's Anna Schoenbaum says the HIMSS Nursing Innovation Advisory Workgroup, which she co-chairs, has developed AI toolkits and customizable teaching slides to help leaders understand AI's complexity, costs and impact.

Christopher McGhee says that, along with the acquisition, Current Health will have a "return to scrappiness and that startup spirit."

Nicole Rogas, RevSpring president, says health systems can improve the billing experience and collect more revenue by using AI and data analytics to create personalized messages delivered via patients' preferred contact methods.

The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 

The company will use the funds to hasten product development, engineering and go-to-market efforts to meet market demand.  

Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as natural extensions of the human body.

Essex County College's Elvy Vieira says the college is increasing access to health technology jobs by offering a data science degree and credentialing courses, as well as a dual enrollment program for high schoolers.

The company will use the funds to invest in research and development and to scale its voice AI platform.